You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
(方土方)博醫療(02216.HK)熱蒸汽治療系統獲內地批准上市
阿思達克 03-21 10:01
(方土方)博醫療-B(02216.HK)公布,其熱蒸汽治療系統InterVapor(包含熱蒸汽治療設備及一次性使用經支氣管內窺鏡熱蒸汽治療導管,「InterVapor」)正式獲得中國國家藥監局(NMPA)批准上市,標誌著該款全球唯一的產品正式在中國商業化落地。 公司指出,這是中國及全球首個獲得NMPA批准的用於治療慢性阻塞性肺部疾病(Chronic Obstructive Pulmonary Disease,「COPD」或「慢阻肺」)的熱蒸汽能量消融系統,唯一可以在肺段水平實現靶向分次階段治療的微創介入肺減容產品,為中國龐大的重度和極重度慢阻肺患者帶來介入治療方案。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account